Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 2
2007 2
2008 1
2010 2
2011 5
2012 7
2013 5
2014 5
2015 4
2016 5
2017 3
2018 3
2019 5
2020 6
2021 7
2022 7
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Lack of shared neoantigens in prevalent mutations in cancer.
Ragone C, Cavalluzzo B, Mauriello A, Tagliamonte M, Buonaguro L. Ragone C, et al. Among authors: tagliamonte m. J Transl Med. 2024 Apr 10;22(1):344. doi: 10.1186/s12967-024-05110-0. J Transl Med. 2024. PMID: 38600547 Free PMC article.
Cross-reactive CD8+ T cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs).
Cavalluzzo B, Viuff MC, Tvingsholm SA, Ragone C, Manolio C, Mauriello A, Buonaguro FM, Tornesello ML, Izzo F, Morabito A, Hadrup SR, Tagliamonte M, Buonaguro L. Cavalluzzo B, et al. Among authors: tagliamonte m. J Exp Clin Cancer Res. 2024 Mar 20;43(1):87. doi: 10.1186/s13046-024-03004-z. J Exp Clin Cancer Res. 2024. PMID: 38509571 Free PMC article.
Corrigendum: Peptide-based vaccine for cancer therapies.
Buonaguro L, Tagliamonte M. Buonaguro L, et al. Among authors: tagliamonte m. Front Immunol. 2023 Oct 26;14:1324894. doi: 10.3389/fimmu.2023.1324894. eCollection 2023. Front Immunol. 2023. PMID: 37965343 Free PMC article.
Peptide-based vaccine for cancer therapies.
Buonaguro L, Tagliamonte M. Buonaguro L, et al. Among authors: tagliamonte m. Front Immunol. 2023 Aug 16;14:1210044. doi: 10.3389/fimmu.2023.1210044. eCollection 2023. Front Immunol. 2023. PMID: 37654484 Free PMC article. Review.
Sorafenib-Loaded PLGA Carriers for Enhanced Drug Delivery and Cellular Uptake in Liver Cancer Cells.
Caputo TM, Cusano AM, Principe S, Cicatiello P, Celetti G, Aliberti A, Micco A, Ruvo M, Tagliamonte M, Ragone C, Minopoli M, Carriero MV, Buonaguro L, Cusano A. Caputo TM, et al. Among authors: tagliamonte m. Int J Nanomedicine. 2023 Jul 26;18:4121-4142. doi: 10.2147/IJN.S415968. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37525693 Free PMC article.
Microorganisms-derived antigens for preventive anti-cancer vaccines.
Buonaguro L, Cavalluzzo B, Mauriello A, Ragone C, Tornesello AL, Buonaguro FM, Tornesello ML, Tagliamonte M. Buonaguro L, et al. Among authors: tagliamonte m. Mol Aspects Med. 2023 Aug;92:101192. doi: 10.1016/j.mam.2023.101192. Epub 2023 Jun 7. Mol Aspects Med. 2023. PMID: 37295175 Review.
Molecular mimicry and cancer vaccine development.
Tagliamonte M, Cavalluzzo B, Mauriello A, Ragone C, Buonaguro FM, Tornesello ML, Buonaguro L. Tagliamonte M, et al. Mol Cancer. 2023 Apr 26;22(1):75. doi: 10.1186/s12943-023-01776-0. Mol Cancer. 2023. PMID: 37101139 Free PMC article. Review.
73 results